Neuralstem IncAdd to My Watchlist

CUR:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 4.74
    Last
  • 0.07  -1.46%
    Today's Change
  • 4.81
    Previous Close
  • Today
     
    2.47
    8.14
    52 Week Low - High
8:10 pm ET 4/28/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding11 million
Market Cap$52 million
Return on Equity ttm-258.77%
Last DividendCUR:US does not pay a dividend
Earnings
EPS: Year Actual ttm-2.658
EPS: Year Est. 12/17 ttm-2.260
 
EPS: Quarterly Actual 12/16 -0.45
EPS: Quarterly Est. 3/17 -0.52
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate15.38
Company Description
Neuralstem Inc. provides medical research services. The Company develops and commercializes clinical treatment for central nervous system diseases. Neuralstem serves the medical field worldwide.
Revenue$16,246
Net Income$-21 million
Total Assets$23 million
Employees11
Web Sitewww.neuralstem.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!